Name | Number of supported studies | Average coverage | |
---|---|---|---|
conventional dendritic cell | 22 studies | 28% ± 13% | |
classical monocyte | 18 studies | 30% ± 11% | |
monocyte | 11 studies | 26% ± 9% | |
non-classical monocyte | 9 studies | 24% ± 9% | |
dendritic cell | 8 studies | 32% ± 14% | |
macrophage | 6 studies | 23% ± 6% | |
mononuclear phagocyte | 5 studies | 28% ± 11% | |
myeloid cell | 3 studies | 27% ± 7% | |
neutrophil | 3 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of CLEC4A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 457.10 | 578 / 578 | 12% | 0.21 | 138 / 1155 |
ovary | 100% | 211.68 | 180 / 180 | 10% | 0.14 | 43 / 430 |
breast | 100% | 149.69 | 458 / 459 | 7% | 0.12 | 74 / 1118 |
bladder | 100% | 136.29 | 21 / 21 | 6% | 0.10 | 28 / 504 |
intestine | 100% | 145.99 | 964 / 966 | 6% | 0.08 | 29 / 527 |
kidney | 96% | 107.00 | 85 / 89 | 7% | 0.10 | 65 / 901 |
brain | 94% | 81.24 | 2477 / 2642 | 7% | 0.12 | 51 / 705 |
thymus | 100% | 127.48 | 650 / 653 | 1% | 0.01 | 4 / 605 |
uterus | 99% | 174.91 | 169 / 170 | 1% | 0.02 | 3 / 459 |
spleen | 100% | 675.20 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 1413.91 | 928 / 929 | 0% | 0 | 0 / 0 |
prostate | 100% | 163.10 | 244 / 245 | 0% | 0.00 | 1 / 502 |
adipose | 100% | 199.04 | 1201 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 157.20 | 1328 / 1335 | 0% | 0 | 0 / 0 |
liver | 98% | 93.15 | 222 / 226 | 0% | 0.00 | 1 / 406 |
adrenal gland | 98% | 97.34 | 252 / 258 | 0% | 0 | 0 / 230 |
stomach | 89% | 75.89 | 318 / 359 | 8% | 0.15 | 22 / 286 |
esophagus | 95% | 92.36 | 1375 / 1445 | 1% | 0.02 | 2 / 183 |
pancreas | 88% | 63.28 | 287 / 328 | 8% | 0.10 | 14 / 178 |
skin | 85% | 105.32 | 1531 / 1809 | 3% | 0.06 | 16 / 472 |
heart | 79% | 61.58 | 676 / 861 | 0% | 0 | 0 / 0 |
muscle | 65% | 39.57 | 518 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 24% | 0.51 | 7 / 29 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.08 | 3 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002250 | Biological process | adaptive immune response |
GO_0061760 | Biological process | antifungal innate immune response |
GO_0002470 | Biological process | plasmacytoid dendritic cell antigen processing and presentation |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_0007155 | Biological process | cell adhesion |
GO_0007166 | Biological process | cell surface receptor signaling pathway |
GO_0036037 | Biological process | CD8-positive, alpha-beta T cell activation |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0042590 | Biological process | antigen processing and presentation of exogenous peptide antigen via MHC class I |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0005537 | Molecular function | D-mannose binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0030246 | Molecular function | carbohydrate binding |
Gene name | CLEC4A |
Protein name | C-type lectin domain family 4 member A (C-type lectin DDB27) (C-type lectin superfamily member 6) (Dendritic cell immunoreceptor) (Lectin-like immunoreceptor) (CD antigen CD367) C-type lectin domain family 4 member A |
Synonyms | LLIR CLECSF6 HDCGC13P DCIR |
Description | FUNCTION: C-type lectin receptor that binds carbohydrates mannose and fucose but also weakly interacts with N-acetylglucosamine (GlcNAc) in a Ca(2+)-dependent manner . Involved in regulating immune reactivity . Once triggered by antigen, it is internalized by clathrin-dependent endocytosis and delivers its antigenic cargo into the antigen presentation pathway resulting in cross-priming of CD8(+) T cells. This cross-presentation and cross-priming are enhanced by TLR7 and TLR8 agonists with increased expansion of the CD8(+) T cells, high production of IFNG and TNF with reduced levels of IL4, IL5 and IL13 . In plasmacytoid dendritic cells, inhibits TLR9-mediated IFNA and TNF production . May be involved via its ITIM motif (immunoreceptor tyrosine-based inhibitory motifs) in the inhibition of B-cell-receptor-mediated calcium mobilization and protein tyrosine phosphorylation . .; FUNCTION: (Microbial infection) Involved in the interaction between HIV-1 virus and dendritic cells. Enhances HIV-1 binding/entry and virus infection. Requires ITIM motif-associated signal transduction pathway involving phosphatases PTPN6 and PTPN11, SYK, Src kinases and MAP kinases. . |
Accessions | A0A286YF15 ENST00000345999.9 [Q9UMR7-4] ENST00000641376.1 Q9UMR7 ENST00000360500.5 [Q9UMR7-3] ENST00000352620.9 [Q9UMR7-2] ENST00000229332.12 [Q9UMR7-1] |